Advantage X? Zuckerberg’s Threads Tangles With Slow Growth As Web Launch Falls Flat

On a global scale, the impact of the web launch was only a 3% increase in website traffic. 

New data suggests that the highly-anticipated web launch of Meta Platforms Inc.’s (NASDAQ:METAThreads, which took place last month, has failed to generate significant growth in its user base. 

What Happened: The release of Threads’ web app was met with high expectations, as users had long been clamoring for a fully functional web version of the popular Twitter, now rebranded as X alternative. 

However, the latest data paints a discouraging picture for the platform, reported TechCrunch, citing Similarweb. 

See Also: Cristiano Ronaldo Hits 600 Million Instagram Followers, Topping Lionel Messi, Selena Gomez

Existing Users Making the Shift: In the U.S., the launch led to a 20% increase in Threads’ website traffic over the past week compared to the week prior. However, it’s unclear whether this spike resulted from new users joining the platform or existing ones transitioning from the native mobile app to the web.

Global Impact Minimal: On a global scale, the impact of the web launch was only a 3% increase in website traffic. 

Naturally, Elon Musk, who acquired Twitter for $44 billion in 2022, has not missed any opportunity to announce the fact that his social media platform still holds sway with features like search, hashtags, and trends that foster real-time conversations—a strength that Threads has yet to replicate successfully.

Mark Zuckerberg has also received backlash for not being as active on the platform as he was during the launch in July and compared to the owner of Threads’ rival platform. 

Why It’s Important: Threads’ struggles began shortly after its explosive debut, with Sensor Tower reporting an 82% drop in daily active users since its launch, leaving the platform with a mere 8 million daily users, the report noted.  

The platform attracted 100 million signups just five days after its launch but has since witnessed a drastic decline in user growth and engagement. 

Check out more of Benzinga’s Consumer Tech coverage by following this link.

Read Next: Meta Wants To Empower Users Over AI Influence On Facebook and Instagram Recommendations

Illustration by Leefuji on Shutterstock

Total
0
Shares
Related Posts
Read More

Jaguar Health Announces Publication In Breast Cancer Research And Treatment Of Investigator-Initiated Phase 2 HALT-D Study Of Crofelemer For Prevention Of Chemotherapy-Induced Diarrhea In Breast Cancer Patients

Results of the study provide the first proof-of-concept data for potential use of crofelemer - a novel, oral, plant-based, non-opioid antidiarrheal prescription medication - in breast cancer patients SAN FRANCISCO, CA /

JAGX